QUIPT HOME MEDICAL CORP. ANNUAL INFORMATION FORM for the year ended

QUIPT HOME MEDICAL CORP.

ANNUAL INFORMATION FORM

for the year ended September 30, 2021

REGARDING FORWARD-LOOKING STATEMENTS

This Annual Information Form ("AIF")

contains certain "forward-looking information" within the meaning of Canadian securities legislation and "forward-looking

statements" within the meaning of applicable securities legislation, including the United States Private Securities Litigation

Reform Act of 1995 (collectively, "forward-looking statements") . Forward-looking statements are neither historical

facts nor assurances of future performance. Instead, they are based upon the current beliefs, expectations, and assumptions regarding

the future of its business, future plans and strategies, and other future conditions of Quipt Home Medical Corp. (the "Company"

or "Quipt"). Forward-looking statements can be identified by the words such as "expect", "likely",

"may", "will",, "would", "could", "should", "continue", "contemplate",

"intend", or "anticipate", "believe", "envision", "estimate", "expect",

"plan", "predict", "project", "target", "potential", "proposed",

"estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain

events or conditions "may" or "will" happen, or by discussions of strategy. Forward-looking statements include

estimates, plans, expectations, opinions, forecasts, projections, targets, guidance, or other statements that are not statements

of fact. Such forward-looking statements are made as of the date of this AIF.

Forward-looking statements in this AIF therein

include, but are not limited to, statements with respect to: operating results; profitability; financial condition and

resources; anticipated needs for working capital; liquidity; capital resources; capital expenditures; milestones;

licensing milestones; information with respect to future growth and growth strategies; anticipated trends in the industry

in with the Company operates; the Company's future financing plans; timelines; currency fluctuations; government

regulation; unanticipated expenses; commercial disputes or claims; limitations on insurance coverage; availability

and expectations regarding of cash flow to fund capital requirements; the product offerings of the Company; the competitive

conditions of the industry; the competitive and business strategies of the Company; on-going implications of the novel coronavirus

("COVID-19"); statements relating to the business and future activities of, and developments related to, the Company,

including such things as future business strategy, competitive strengths, goals, expansion and growth of the Company's

business, operations and plans; and other events or conditions that may occur in the future.

Forward-looking statements are based on the reasonable

assumptions, estimates, analysis and opinions of the Company's management made in light of its experience and its perception

of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable

in the circumstances at the date that such statements are made, but which may prove to be incorrect. The Company believes that

the assumptions and expectations reflected in such forward-looking statements are reasonable. The material factors and assumptions

used to develop the forward-looking statements contained in this AIF, without limitation: the Company's ability to successfully

execute its growth strategies and business plan; the ability to successfully identify strategic acquisitions; the Company's

ability to realize anticipated benefits, synergies or generate revenue, profits or value from its recent acquisitions into existing

operations; management's perceptions of historical trends, current conditions and expected future developments; the ability

of the Company to take market share from competitors; the Company's ability to attract and retain skill staff; market

conditions and competition; the products, services and technology offered by the Company's competitors; the Company's

ability to generate cash flow from operations the Company's ability to keep pace with changing regulatory requirements; ongoing

ability to conduct business in the regulatory environments in which the Company operates and may operate in the future; that

the Company's ability to maintain strong business relationships with its suppliers, service provides and other third parties

will be maintained; COVID-19 and recall related supply chain issues will be resolved within the near future; the Company's

ability to fulfill prescriptions for services and products; the anticipated growth of the niche market of home equipment and monitoring;

the anticipated increase in demand for various medical products and equipment; demand and interest in the Company's products

and services; the ability to deploy up front capital to purchase monitoring and treatment equipment; anticipated and unanticipated

costs; the timely receipt of any required regulatory authorizations, approvals, consents, permits and/or licenses; the general

economic, financial market, regulatory and political conditions in which the Company operates and the absence of material adverse

changes in the Company's industry, regulatory environmental or the global economy; and other considerations that management

believes to be appropriate in the circumstances.

Forward-looking statements speak only as at the

date they are made and are based on information currently available and on the then current expectations. Readers are cautioned that

forward- looking statements are not based on historical facts but instead are based on reasonable assumptions and estimates of

management of the Company at the time they were provided or made and involve known and unknown risks, uncertainties and other

factors which may cause the actual results, performance or achievements of the Company, as applicable, to be materially different

from any future results, performance or achievements expressed or implied by such forward-looking statements, including,

but not limited to, known and unknown risks, uncertainties, assumptions and other factors, including those listed under "Risk

Factors", which include: credit risks, market risks (including those related to equity, commodity, foreign exchange and

interest rate markets), liquidity risks, operational risks (including those related to technology and infrastructure), and risks

relating to reputation, insurance, strategy, regulatory matters, legal matters, environmental matters and capital adequacy. Examples

of such risk factors include: the Company may be subject to significant capital requirements and operating risks; changes in

law, the ability to implement business strategies, growth strategies and pursue business opportunities; state of the capital markets;

the availability of funds and resources to pursue operations; decline of reimbursement rates; dependence on few payors; possible

new drug discoveries; a novel business model; dependence on key suppliers; granting of permits and licenses in a highly regulated

business; competition; difficulty integrating newly acquired businesses; low profit market segments; disruptions in or attacks (including

cyber-attacks) on information technology, internet, network access or other voice or data communications systems or services; the

evolution of various types of fraud or other criminal behaviour; the failure of third parties to comply with their obligations; the

impact of new and changes to, or application of, current laws and regulations; the overall difficult litigation environment,

including in the United States; risks related to infectious diseases, including the impacts of COVID-19; increased competition;

changes in foreign currency rates; loss of foreign private issuer status; risks relating to the deterioration of global economic

conditions; increased funding costs and market volatility due to market illiquidity and competition for funding; critical accounting

estimates and changes to accounting standards, policies, and methods; and the occurrence of natural and unnatural catastrophic events

and claims resulting from such events, as well as other general economic, market and business conditions, amongst others, as

well as those risk factors described under the heading "Risk Factors" and elsewhere in this AIF and therein and

as described from time to time in documents filed by the Company with Canadian securities regulatory authorities including, without

limitation, Company's audited annual financial statements and the Company's management's discussion and analysis ("MD&A").

Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially

from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as

anticipated, estimated or intended. The Company provides no assurance that forward-looking statements will prove to be accurate,

as actual results and future events could differ materially from those anticipated in such statements.

Readers are cautioned that the above list of cautionary

statements is not exhaustive. A number of factors could cause actual events, performance or results to differ materially from what

is projected in forward-looking statements. The purpose of forward-looking statements is to provide the reader with a description

of management's expectations, and such forward-looking statements may not be appropriate for any other purpose. You should

not place undue reliance on forward-looking statements contained in this AIF. Although the Company believes that the expectations

reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have

been correct. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new

information, future events or otherwise, except as required by applicable law. The forward-looking statements contained in this AIF

are expressly qualified in their entirety by this cautionary statement.

Unless the context otherwise requires, all references

to "$", "C$" or "dollars" mean references to the lawful money of Canada. All references

to "US$" refer to United States dollars.

The following table sets forth (a) the rate

of exchange for the Canadian dollar, expressed U.S. dollars, in effect for the periods indicated; and (b) the high and low exchange

rates for the Canadian dollar, expressed in U.S. dollars, during the periods indicated, each based on the indicative rate of exchange

as reported by the Bank of Canada for conversion of Canadian dollars into U.S. dollars.